Posted in | News | Imaging

Exosens and Theon Extend Long-Term Commercial Agreement Through 2030 to Secure Image Intensifier Tube Capacity in a Market Constrained by Growing Demand

    Exosens, a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology and Theon International, a leading developer and manufacturer of customizable night vision and thermal imaging systems for defense and security applications, are pleased to announce the extension of their long-term commercial agreement for the supply of Image Intensifier Tubes. This agreement, originally set to expire in 2027, has now been extended by three additional years, covering deliveries potentially through the end of 2030.

    A Strengthened Partnership to Meet Growing Global Demand

    This extension represents a significant contribution to the collaboration between the two companies. Within the scope of this extension, Theon will exercise its options for 2027 and 2028 before the end of the year, converting them into firm committed orders. It solidifies Exosens' role as a preferred supplier to European Armed Forces and global markets. It also ensures that Theon will purchase and receive an increased annual supply of image intensifier tubes compared to the original agreement, enabling it to meet the rising demand for night vision devices across Europe, as well as in the MENA (Middle East and North Africa) and APAC (Asia-Pacific) regions.

    Exosens and Theon Well Positioned to Address Supply Constraints

    With the global supply of image intensifier tubes remaining structurally below demand despite recent capacity expansions, Exosens and Theon are positioning themselves as key players in ensuring supply security for their customers. Exosens' investments, notably driven by Theon's and growing order and market prospects, enable the company to meet increasing market needs while driving technological advancements.

    Under this agreement, Theon can procure up to over 400,000 tubes over the next five years, reinforcing Exosens' global leadership in the image intensifier tube market and enabling it to continue expanding its capacity and smoothen out balance of production throughout the years.

    A Historic Collaboration With a Shared Vision

    Jérôme Cerisier, CEO of Exosens, commented: "We are delighted with this extension of our agreement with Theon, our largest customer for image intensifier tubes. This partnership reflects the strength of our long-standing relationship and our shared vision on growing demand in the night vision solutions. We are committed to delivering cutting-edge night vision solutions to end-users worldwide. Exosens is taking part to Europe's technological sovereignty and the security of growing supply of armed forces and strategic industries."

    Source:

    Citations

    Please use one of the following formats to cite this article in your essay, paper or report:

    • APA

      Exosens. (2025, December 04). Exosens and Theon Extend Long-Term Commercial Agreement Through 2030 to Secure Image Intensifier Tube Capacity in a Market Constrained by Growing Demand. AZoOptics. Retrieved on December 04, 2025 from https://www.azooptics.com/News.aspx?newsID=30555.

    • MLA

      Exosens. "Exosens and Theon Extend Long-Term Commercial Agreement Through 2030 to Secure Image Intensifier Tube Capacity in a Market Constrained by Growing Demand". AZoOptics. 04 December 2025. <https://www.azooptics.com/News.aspx?newsID=30555>.

    • Chicago

      Exosens. "Exosens and Theon Extend Long-Term Commercial Agreement Through 2030 to Secure Image Intensifier Tube Capacity in a Market Constrained by Growing Demand". AZoOptics. https://www.azooptics.com/News.aspx?newsID=30555. (accessed December 04, 2025).

    • Harvard

      Exosens. 2025. Exosens and Theon Extend Long-Term Commercial Agreement Through 2030 to Secure Image Intensifier Tube Capacity in a Market Constrained by Growing Demand. AZoOptics, viewed 04 December 2025, https://www.azooptics.com/News.aspx?newsID=30555.

    Tell Us What You Think

    Do you have a review, update or anything you would like to add to this news story?

    Leave your feedback
    Your comment type
    Submit

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.